Cell Death and Disease · 2018 · 218 citations · 34 references
MedicineOncologyPharmacologyApoptosisCancer PharmacologyMetastasisCancer Cell SignalingCancer MetabolismMalignant NeoplasmsMetastatic Signaling PathwaysPentose Phosphate PathwayPentose Phosphate Pathway RegulationEndoplasmic Reticulum StressEndoplasmic Reticulum Stress ApoptosisEndoplasmic Reticulum Stress ResponsesLymph Node MetastasesMetabolic Pathway InhibitionOrthotopic Tumor ModelsPhase Ii Clinical TrialsTumor Metabolism
Pentose phosphate pathway (PPP) is a major glucose metabolism pathway, which has a fundamental role in cancer growth and metastasis. Even though PPP blockade has been pointed out as a very promising strategy against cancer, effective anti-PPP agents are not still available in the clinical setting. Here we demonstrate that the natural molecule polydatin inhibits glucose-6-phosphate dehydrogenase (G6PD), the key enzyme of PPP. Polydatin blocks G6PD causing accumulation of reactive oxygen species and strong increase of endoplasmic reticulum stress. These effects are followed by cell cycle block in S phase, an about 50% of apoptosis, and 60% inhibition of invasion in vitro. Accordingly, in an orthotopic metastatic model of tongue cancer, 100 mg/kg polydatin induced an about 30% tumor size reduction with an about 80% inhibition of lymph node metastases and 50% reduction of lymph node size (p < 0.005). Polydatin is not toxic in animals up to a dose of 200 mg/kg and a phase II clinical trial shows that it is also well tolerated in humans (40 mg twice a day for 90 days). Thus, polydatin may be used as a reliable tool to limit human cancer growth and metastatic spread.
34
Oxidative stress inhibits distant metastasis by human melanoma cells
Elena Piskounova, Michalis Agathocleous, Malea M. Murphy et al. · Nature · 2015 · 1.3K citations
Medicine, Cancer Biology, Oncology +14
Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma
Mara Compagno, Wei Keat Lim, Adina Grunn et al. · Nature · 2009 · 1K citations